2021
DOI: 10.1016/j.vaccine.2021.10.054
|View full text |Cite
|
Sign up to set email alerts
|

COVID-19 vaccination significantly reduces morbidity and absenteeism among healthcare personnel: A prospective multicenter study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
32
1

Year Published

2021
2021
2023
2023

Publication Types

Select...
9

Relationship

6
3

Authors

Journals

citations
Cited by 33 publications
(33 citation statements)
references
References 23 publications
0
32
1
Order By: Relevance
“…Median overall incidence density of SARS-CoV-2 infection during the study period was 3.39 [2.89-3.96] per 1000 person-month (0.19 [0.08-0.36] during the third wave, 1.04 [0.77-1.37] during the fourth wave, and 2.17 [1.77-2.64] during the fifth wave). The incidence at 3 and 6 months of complete vaccination was 7 [5] , [6] , [7] , [8] , [9] , [10] and 12 [9–15] per 1000 person-month respectively.
Figure 1 Flow-chart of the study.
…”
Section: Resultsmentioning
confidence: 99%
“…Median overall incidence density of SARS-CoV-2 infection during the study period was 3.39 [2.89-3.96] per 1000 person-month (0.19 [0.08-0.36] during the third wave, 1.04 [0.77-1.37] during the fourth wave, and 2.17 [1.77-2.64] during the fifth wave). The incidence at 3 and 6 months of complete vaccination was 7 [5] , [6] , [7] , [8] , [9] , [10] and 12 [9–15] per 1000 person-month respectively.
Figure 1 Flow-chart of the study.
…”
Section: Resultsmentioning
confidence: 99%
“…COVID-19 represents an occupational risk for dentists [ 10 , 20 , 21 ]. Vaccination against COVID-19 significantly reduces morbidity and absenteeism among HCP [ 22 ]. However, in many settings, HCP have been hesitant to have a COVID-19 vaccine.…”
Section: Discussionmentioning
confidence: 99%
“…In randomized, placebo-controlled, phase 3 efficacy trials after vaccine rollout, both mRNA vaccines were efficient in inhibiting symptomatic and severe COVID-19 illness [14][15][16][17]. Furthermore, a recent study showed that full vaccination of HCP with mRNA vaccine was associated with 66.42% vaccine effectiveness against absenteeism [18]. In clinical trials, the vaccines had 52-95% efficacy for symptomatic disease 14 days later than the first dose and 95% efficacy 7 days later than the second dose [15,16].…”
Section: Introductionmentioning
confidence: 99%